Diet drug Acomplia gets reprieve in Europe
Diet drug Acomplia (rimonabant) was discussed by European regulators at their June meeting this week, but the only decision reached was to discuss the matter again at their July 16-to-19 meeting.
Read the rest of this entry ... (207 words left)